UPDATE: How the vaccine rollout is going in SA’s provinces
The National Council of Provinces convened on Thursday to receive an update on the country’s vaccine acquisition and rollout plan. Elri Voigt has the details of what provinces reported.
Opinion: Health budget slashed despite vaccine commitments
The national budget tabled this week shows that planned spending on public health is reduced by a massive R50.3 billion over the next three years. We cannot accept a vaccine versus health system trade-off. Government must both expedite the procurement of vaccines and ensure that provinces have the staff and other capabilities to rapidly roll them out and to maintain and improve the quality of healthcare services, argue writers from SECTION27.
Opinion: Mboweni didn’t deliver on a 20% health promotion levy. Here’s why it is anti-poor.
Every year that National Treasury cannot deliver a health promotion levy of 20%, people in South Africa will die from the diseases that this levy could help prevent. And it is the poorest in South Africa who are the hardest hit, argues Lawrence Mbalati.
Analysis: What can SA do about the ‘slow violence’ of child hunger and malnutrition?
The 2020 edition of the South African Child Gauge released last week once again placed the spotlight on the country’s child hunger and nutrition crisis. Various specifics in the new budget being presented in parliament today will tell us how committed government is in addressing this crisis, writes Kathryn Cleary.
New men’s health centre in Cape metro welcomed
The Western Cape Department of Health recently opened a new men’s only health centre, which aims to empower boys and men to lead healthy lives. Siyabonga Kamnqa spoke to the centre’s manager and men’s health organisations about the value this centre will add and the services it provides.
Face to face with Gift of the Givers founder Imtiaz Sooliman
Gift of the Givers founder Dr Imtiaz Sooliman has declined social media calls that he be nominated for the 2021 Nobel Peace Prize. Bienne Huisman spoke to Sooliman about the organisation’s work during the pandemic, his background, and what keeps him going.
Rolling out the vaccine: Provincial plans compared
Provinces manage the day-to-day running of the public healthcare system in South Africa and provinces will be responsible for the massive logistical effort of getting COVID-19 vaccines from fridges and depots into people’s arms. Elri Voigt has been keeping track of the nine provinces’ plans.
Medical oxygen: The fascinating journey of a life-saving gas
Even in ‘normal’ times a reliable supply of medical oxygen is an essential part of healthcare services, but during COVID-19 surges the need for this life-sustaining gas has spiked to unprecedented levels. Tiyese Jeranji explores the fascinating science and engineering that facilitates this substance’s long journey from a production plant to a person’s lungs.
Navigating abortion barriers in rural areas
Among several significant barriers to accessing abortion services, experts cite a lack of management support at health facilities, costs, fear of breach of confidentiality and stigma. Many of these barriers are compounded in rural areas. Tiyese Jeranji reports.
COVID-19 in kids: What have we learnt one year later?
It has been over a year since the world saw the first confirmed case of COVID-19, yet the science behind the virus’ physical impact on children remains relatively unclear. Kathryn Cleary spoke to two experts in paediatrics and immunology to get an update on what we have learnt so far.
Eastern Cape: Questions over vaccine readiness in rural areas
The shortcomings of healthcare services in the rural Eastern Cape is well documented. Now, with provinces gearing up for the COVID-19 vaccine rollout, Luvuyo Mehlwana asked local health activists and government leaders about the rollout plan for rural communities in the province.
Opinion: Pivot to J&J vaccine makes sense in light of new findings
Government deserves criticism for various aspects of its COVID-19 response, but some social media criticism following Sunday’s announcement that the Oxford University/AstraZeneca vaccine has little or no efficacy in preventing mild-to-moderate disease caused by the 501Y.V2 variant has been unfair, writes Marcus Low.